129 related articles for article (PubMed ID: 25282877)
1. [Advance in studies on TRPV1 and analgesic effect of traditional Chinese medicines].
Liu XL; Lv C; Zhang WS
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1757-60. PubMed ID: 25282877
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study on two-way application of drugs with neutral property for promoting blood circulation and removing blood stasis on cold and heat blood stasis syndromes II].
Hao EW; Deng JG; Du ZC; Zheng ZW; Yang K; Wang Q; Tang YL; Bao CH; Lu XY; Tang ZL; Deng XQ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):605-10. PubMed ID: 23713291
[TBL] [Abstract][Full Text] [Related]
3. A Chinese Herbal Decoction, Shaoyao-Gancao Tang, Exerts Analgesic Effect by Down-Regulating the TRPV1 Channel in a Rat Model of Arthritic Pain.
Sui F; Zhou HY; Meng J; Du XL; Sui YP; Zhou ZK; Dong C; Wang ZJ; Wang WH; Dai L; Ma H; Huo HR; Jiang TL
Am J Chin Med; 2016; 44(7):1363-1378. PubMed ID: 27785943
[TBL] [Abstract][Full Text] [Related]
4. [Study on relations between transient receptor potential vanilloid 1 and pungent property of traditional Chinese medicines].
Wang X; Zhang YL; Wang Y; Ren ZZ; Bao HJ; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2422-7. PubMed ID: 25276957
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on two-way application of traditional Chinese medicines capable of promoting blood circulation and removing blood stasis with neutral property in cold and hot blood stasis syndrome I].
Hao EW; Deng JG; Du ZC; Yan K; Zheng ZW; Wang Q; Huang LZ; Bao CH; Deng XQ; Lu XY; Tang ZL
Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(21):3302-6. PubMed ID: 23397734
[TBL] [Abstract][Full Text] [Related]
6. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
8. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications.
Cui M; Gosu V; Basith S; Hong S; Choi S
Adv Protein Chem Struct Biol; 2016; 104():81-125. PubMed ID: 27038373
[TBL] [Abstract][Full Text] [Related]
9. Multisteric TRPV1 nocisensor: a target for analgesics.
Szolcsányi J; Sándor Z
Trends Pharmacol Sci; 2012 Dec; 33(12):646-55. PubMed ID: 23068431
[TBL] [Abstract][Full Text] [Related]
10. TRPV1: a therapeutic target for novel analgesic drugs?
Szallasi A; Cruz F; Geppetti P
Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin receptor: TRPV1 a promiscuous TRP channel.
Pingle SC; Matta JA; Ahern GP
Handb Exp Pharmacol; 2007; (179):155-71. PubMed ID: 17217056
[TBL] [Abstract][Full Text] [Related]
12. Modulation of transient receptor potential (TRP) channels by Chinese herbal extracts.
Zhang Y; Sreekrishna K; Lin Y; Huang L; Eickhoff D; Degenhardt C; Xu T
Phytother Res; 2011 Nov; 25(11):1666-70. PubMed ID: 21432926
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.
Szolcsányi J; Pintér E
Expert Opin Ther Targets; 2013 Jun; 17(6):641-57. PubMed ID: 23421411
[TBL] [Abstract][Full Text] [Related]
15. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Szallasi A; Cortright DN; Blum CA; Eid SR
Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature.
Voight EA; Kort ME
Expert Opin Ther Pat; 2010 Sep; 20(9):1107-22. PubMed ID: 20586701
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
18. Role of TRPV1 receptors in descending modulation of pain.
Palazzo E; Rossi F; Maione S
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659
[TBL] [Abstract][Full Text] [Related]
19. TRPV1 signaling: mechanistic understanding and therapeutic potential.
Xia R; Samad TA; Btesh J; Jiang LH; Kays I; Stjernborg L; Dekker N
Curr Top Med Chem; 2011; 11(17):2180-91. PubMed ID: 21671876
[TBL] [Abstract][Full Text] [Related]
20. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
